The U.S. Food and Drug Administration’s database indicates that the abbreviated new drug application (ANDA) 087157 for the product FLUONID has a marketing status of "Discontinued." FLUONID is a topical ointment containing 0.025% fluocinonide. The product is not designated as a reference drug and does not have a reference standard. The sponsor listed for this ANDA is Allergan Herbert. No further details on the reason for discontinuation are provided in the FDA entry.
Regulatory UpdatesSep 5, 2026•1 min read
FDA Discontinues FLUONID Topical Ointment (ANDA 087157)
The FDA lists the FLUONID ointment (0.025% fluocinonide) under ANDA 087157 as discontinued, sponsored by Allergan Herbert.
Compiled by the PharmaCountry team · Source: FDA.gov
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating